Regeneron Pharmaceuticals, Inc. (REGN)
Regeneron Pharmaceuticals, Inc. (REGN) is a Healthcare stock tracked by StreetAlpha. REGN reports earnings on Fri, Oct 30, 2026. Analyst consensus is Buy, based on the latest ratings from 11 firms (6 buy, 5 hold, 0 sell). Over the past 90 days StreetAlpha recorded 7 whale options trades in REGN, 29% of them bullish and 71% bearish. In the past 30 days there were 9 dark pool prints.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 8 | RBC Capital | Target raised | Hold | — |
| Oct 7 | Truist Securities | Target raised | Buy | — |
| Oct 7 | Morgan Stanley | Target raised | Hold | — |
| Oct 1 | Jefferies | Maintained | Buy | — |
| Oct 1 | Argus Research | Upgrade | Buy | — |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether REGN is in one of them and how their past REGN trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered REGN in an article yet. Here's the latest on the wider market.
REGN Congress Trades
All congress trades →
| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Donald J TrumpExecutive branch | Buy | $50K – $100K | Jul 23, 2026 | Sep 22, 2026 | 61 d |
| Donald J TrumpExecutive branch | Buy | $1K – $15K | Jul 17, 2026 | Sep 22, 2026 | 67 d |
| Ro KhannaD · CA | Buy | $1K – $15K | Jul 7, 2026 | Aug 12, 2026 | 36 d |
| Alan ArmstrongHouse | Buy | $1K – $15K | Mar 27, 2026 | Jul 21, 2026 | 116 d |
| Donald J TrumpExecutive branch | Sell | $1K – $15K | May 18, 2026 | Jul 1, 2026 | 44 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.